UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049930
Receipt number R000054317
Scientific Title Validation of Quality of Life Interview Scale (SEIQoL) online
Date of disclosure of the study information 2022/12/28
Last modified on 2022/12/28 10:40:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation of Quality of Life Interview Scale (SEIQoL) online

Acronym

Validation of Quality of Life Interview Scale

Scientific Title

Validation of Quality of Life Interview Scale (SEIQoL) online

Scientific Title:Acronym

Validation of SEIQoL online

Region

Japan


Condition

Condition

healthy population; cancer patients

Classification by specialty

Medicine in general Surgery in general Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to test the reliability and validity of the SEIQoL scale in cancer patients.

Basic objectives2

Others

Basic objectives -Others

The aim of this study is to test the responsivility of the SEIQoL scale in cancer patients.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Quality of Life

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Stress Management Program

Interventions/Control_2

Usual care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who have been diagnosed with cancer within 5 years; who is able to operate a computer, tablet, etc. on their own; who have no difficulty in reading and writing Japanese.

Key exclusion criteria

Patients who are judged by their doctor to have difficulty participating in the program.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kanako
Middle name
Last name Ichikura

Organization

Kitasato University School of Allied Health Sciences

Division name

Department of Health Science

Zip code

252-0373

Address

1-15-1, Kitazato, Minami-ku, Sagamihara, Kanagawa

TEL

042-778-8031

Email

ichikura@kitasato-u.ac.jp


Public contact

Name of contact person

1st name Ichikura
Middle name
Last name Kanako

Organization

Kitasato University School of Allied Health Sciences

Division name

Department of Health Science

Zip code

252-0373

Address

1-15-1, Kitazato, Minami-ku, Sagamihara, Kanagawa

TEL

042-778-8031

Homepage URL


Email

ichikura@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University

Institute

Department

Personal name

Kanako Ichikura


Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Tokyo Medical and Dental University; Tokyo Metropolitan Ohtsuka Hospital; Edogawa Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

None

Address

None

Tel

None

Email

None


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学病院/都立大塚病院/江戸川病院


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 12 Month 22 Day

Date of IRB

2022 Year 12 Month 13 Day

Anticipated trial start date

2022 Year 12 Month 28 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 28 Day

Last modified on

2022 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054317


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name